Skip to main content
. 2022 Apr 13;13:868229. doi: 10.3389/fimmu.2022.868229

Figure 1.

Figure 1

miRNAs control MLCK/p-MLC and Rho/ROCK/p-MLC signaling pathway in IBD. (A) miR-1, miR-185-3p, and miR-200b target and inhibit MLCK or p-MLC levels to block the recombination of TJ proteins, and possibly reverse the impaired intestinal barrier function in IBD. (B) miR-21, miR-31, and miR-199a-5p respectively target and downregulate RhoB, RhoA, and ROCK1 levels, and possibly inhibit the progress of IBD.